Johnson Matthey PLC (LON:JMAT) insider Robert MacLeod bought 5,250 shares of the firm’s stock in a transaction dated Monday, November 25th. The stock was purchased at an average price of GBX 2,842 ($37.14) per share, for a total transaction of £149,205 ($194,962.76).
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.
Shares of LON:JMAT traded up GBX 64 ($0.84) during midday trading on Monday, hitting GBX 2,910 ($38.02). The company had a trading volume of 765,031 shares, compared to its average volume of 691,012. Johnson Matthey PLC has a twelve month low of GBX 2,574 ($33.63) and a twelve month high of GBX 3,475 ($45.41). The company has a debt-to-equity ratio of 50.40, a current ratio of 1.64 and a quick ratio of 0.95. The stock has a market cap of $5.60 billion and a price-to-earnings ratio of 13.56. The business’s 50-day simple moving average is GBX 3,067.54 and its 200-day simple moving average is GBX 3,103.47.
The business also recently declared a dividend, which will be paid on Tuesday, February 4th. Investors of record on Thursday, November 28th will be issued a GBX 24.50 ($0.32) dividend. The ex-dividend date is Thursday, November 28th. This represents a dividend yield of 0.82%. Johnson Matthey’s dividend payout ratio is presently 0.40%.
Several equities analysts have recently weighed in on JMAT shares. Deutsche Bank decreased their target price on Johnson Matthey from GBX 3,700 ($48.35) to GBX 3,600 ($47.04) and set a “buy” rating on the stock in a research report on Friday. Berenberg Bank cut their price target on Johnson Matthey from GBX 3,750 ($49.00) to GBX 3,600 ($47.04) and set a “buy” rating for the company in a report on Monday. Credit Suisse Group cut their price target on Johnson Matthey from GBX 4,200 ($54.88) to GBX 3,900 ($50.96) and set an “outperform” rating for the company in a report on Wednesday, October 23rd. UBS Group reaffirmed a “sell” rating and issued a GBX 2,700 ($35.28) price target on shares of Johnson Matthey in a report on Monday. Finally, Liberum Capital reaffirmed a “buy” rating on shares of Johnson Matthey in a report on Thursday. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the company’s stock. Johnson Matthey presently has an average rating of “Buy” and a consensus target price of GBX 3,718.57 ($48.59).
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Article: Trading Penny Stocks